Past research suggested that antidepressants might factor into a bleeding risk after surgery. Facelift surgery appeared to be exempt after a recent evaluation.

A testing system commonly used to diagnose heart problems and other medical conditions has been recalled by the U.S. Food and Drug Administration.

Clot-busting drug tissue plasminogen activator ( tPA ) is the only approved treatment for dissolving blood clots common during stroke, heart attacks or pulmonary embolisms.

United States Food and Drug Administration officials today delayed approval of Eliquis ( apixaban ) to prevent stroke or systemic embolism in patients with a common heart arrhythmia for the second time.

An investigational drug appears to offer significant improvements for patients with peripheral artery disease (PAD), a recent trial found.

Filters used to block blood clots from passing to the lungs and creating a potentially life-threatening pulmonary embolism can save patient lives. Yet a trio of new studies suggests they don't reduce the risk of dying. The vena cava filters may reduce the risk of mortality in patients considered "unstable" when they arrive at the hospital, however. Always ask about the benefits and risks of potential therapies. Paul Stein, MD, a lead researcher, professor in osteopathic medical specialties at Michigan State University and director of research at St. Mary Mercy Hospital, noted t...

Following a blood clot patients commonly take warfarin (Coumadin) to prevent a recurrence. It may be just as safe and effective for those individuals to later switch to aspirin.

Following a close vote, a U.S. Food and Drug Administration panel has declined to recommend r ivaroxaban ( Xarelto ) to treat acute coronary syndrome.

After certain types of heart attacks, doctors often use stents to prop open the arteries. Another method that may be used involves removing blood clots through thrombus aspiration (TA), but studies have shown mixed long-term results.

Heart failure patients often take medication to lower their risk of stroke, hemorrhage or dying. A common choice is warfarin (Coumadin), though a large clinical trial has found that cheaper over-the-counter aspirin may be just as effective.